Results 161 to 170 of about 24,189 (241)

Combined C-terminal truncation and point mutations in HBx in genotype D1 HBV-associated hepatocellular carcinoma. [PDF]

Infect Agent Cancer
Yu M, Alkhawaja AS, Mollaei H, Fazila Z, Jasur R, Roudbaneh EM, Roudbaneh EM, Jalali KM.   +7 more
europepmc   +1 more source

A peptide-based PROTAC targeting FOXM1 suppresses fibrosis-associated hepatocarcinogenesis. [PDF]

Theranostics
Wu D, Duan L, Tan D, Hua X, Liang A, Huai R, Qi S, Shang Z, Jia S, Qi H, Liu X, Zhao J, Jiang Y, Tan R, Mao C.   +14 more
europepmc   +1 more source

Beyond Insulin Resistance: Exploring the Centrality of the Gut-Liver Axis in Mediating Immunometabolic Dysregulation Driving Hepatocellular Carcinoma in MASLD and Diabetes. [PDF]

Cancers (Basel)
Romeo M, Basile C, Martinelli G, Di Nardo F, Napolitano C, De Gregorio A, Vaia P, Di Puorto L, Indipendente M, Federico A, Dallio M.   +10 more
europepmc   +1 more source

Inflammation-Driven Downregulation of CYP2E1 Is Associated with Attenuated Diethylnitrosamine (DEN)-Induced Hepatocarcinogenesis. [PDF]

Cells
Tsuchiya Y, Sotomaru Y, Kanai A, Maeda S, Kamata H.   +4 more
europepmc   +1 more source

Biological Roles of Hepatitis B Viral X Protein in the Viral Replication and Hepatocarcinogenesis

Hepatitis B virus is a pathogenic virus that infects 300 million people worldwide and causes chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Hepatitis B virus encodes four proteins.
Otsuka, Motoyuki
core  

Quercetin and low-dose gamma irradiation modulate oxidative stress, inflammation, autophagy, and apoptosis in DEN-induced hepatocarcinogenesis. [PDF]

Genes Nutr
Khatab NS, Elbakary NM, Ali M, Maarouf RE, Zahran F.   +4 more
europepmc   +1 more source

Metabolic dysfunction-associated fatty liver disease in chronic hepatitis B: dual effects on hepatocarcinogenesis and evolving strategies for risk prediction. [PDF]

Front Immunol
Tao H, Duan Y, Yu G, Yan W, Yin J.
europepmc   +1 more source

Circulating tumor DNA for minimal residual disease and recurrence surveillance in hepatocellular carcinoma: current evidence and a translational roadmap. [PDF]

Front Oncol
Gu Y, Luo X, Zhang Y, Tang J, Wang Z.
europepmc   +1 more source

Stemness CD24 activation promotes hepatocellular carcinoma progression <i>via</i> an immune escape mechanism. [PDF]

World J Gastroenterol
Cai Y, Liu LY, Xia XX, Tang H, Xu M, Sai WL, Yao DF, Yao M.   +7 more
europepmc   +1 more source

Experimental hepatocarcinogenesis [PDF]

Hepatology, 2013
openaire   +1 more source